Assignee
GB002 INC
US·0 granted patents·3 pending applications·0 citations·filing 2020–2023
Top patents by PatentIndex Score
3 records- 0165US2026042816A1Tyrosine kinase inhibitor and activin type 2 receptor antagonist combination therapy for treating pulmonary arterial hypertension (pah)GB002 INC·Filed 2023·Application pending·0 cites
- 0258US2024228462A1Crystalline forms of n-{3-[(1s)-1-{[6-(3,4-dimethoxyphenyl)pyrazin-2- yl]amino}ethyl]phenyl}-5-methylpyridine-3-carboxamide and related products and methodsGB002 INC·Filed 2022·Application pending·0 cites
- 0349US2023102554A1Heterocyclic kinase inhibitors and products and uses thereofGB002 INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GB002 INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →